 |
| Sent to you from Drugs.com You received this email because you requested to receive drug alerts. Change your notification settings or unsubscribe here. |
Sent to subscribers of: varenicline systemic July 22, 2011 Audience: Family Medicine, Cardiology. UPDATED 07/22/2011 - FDA has approved an updated drug label for Chantix (varenicline) to include information about the efficacy and safety of the drug in two patient populations who may benefit greatly from giving up smoking - those with cardiovascular disease and those with chronic obstructive pulmonary disease (COPD). The updated label now also includes alternative directions for patients to select a quit smoking date.  |
| Copyright © 2011 Drugs.com. All rights reserved. Change your notification settings or unsubscribe here. |
